Gastrointestinal Stromal Tumor Global Market Report 2024

Description

A gastrointestinal stromal tumor (GIST) is a rare type of non-epithelial tumor that originates in the gastrointestinal (GI) tract. These tumors most commonly develop in the stomach or the small intestine, although they can occur anywhere along the GI tract, from the esophagus to the rectum.

The main treatment modalities for gastrointestinal stromal tumors include chemotherapy, targeted therapy, and others. Chemotherapy is a medical treatment that utilizes potent drugs to target and eliminate rapidly dividing cells in the body, including cancer cells. It is prescribed for various indications such as those affecting the stomach, small intestine, and other parts of the GI tract. Different end-users, including hospitals, clinics, specialized cancer treatment centers, and others, may administer chemotherapy as part of the treatment regimen.

The gastrointestinal stromal tumor market research report is one of a series of new reports from The Business Research Company that provides gastrointestinal stromal tumor market statistics, including gastrointestinal stromal tumor industry global market size, regional shares, competitors with a gastrointestinal stromal tumor market share, detailed gastrointestinal stromal tumor market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal stromal tumor industry. This gastrointestinal stromal tumor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gastrointestinal stromal tumor market size has grown strongly in recent years. It will grow from $1.18 billion in 2023 to $1.28 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The growth observed in the historical period can be attributed to increased awareness and early diagnosis, the emergence of targeted therapies, enhanced surgical techniques, the development of personalized medicine, and improvements in supportive care.

The gastrointestinal stromal tumor market size is expected to see strong growth in the next few years. It will grow to $1.69 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The anticipated growth in the forecast period can be attributed to continued research and drug development, a rise in patient-centric healthcare, the integration of precision medicine into clinical practice, increasing access to targeted therapies, and expanding genomic profiling capabilities. Key trends expected in the forecast period include growing collaboration in research and development, advancements in diagnostic technologies, collaborative research and clinical trials, increased focus on early detection and diagnosis, and exploration of combination therapies.

The anticipated increase in stomach cancer cases is poised to drive the growth of the gastrointestinal stromal tumor market. Stomach cancer, characterized by the uncontrolled growth of malignant cells in the stomach lining, is distinct from gastrointestinal stromal tumors (GISTs), although GISTs can occur in the stomach. Interestingly, individuals with GISTs who develop two separate tumors that merge into one have an elevated risk of additional cancers, including small bowel adenocarcinoma. For example, Cancer Research UK projects a 12% decline in stomach cancer incidence in the UK between 2023-2025 and 2038-2040, reaching an average of 8 cases per 100,000 people annually. Thus, the increasing occurrence of stomach cancer is a key driver propelling the gastrointestinal stromal tumor market.

The growing demand for precision medicine is expected to fuel the expansion of the gastrointestinal stromal tumor market. Precision medicine, tailored to individual patient characteristics such as genetics and lifestyle, is a targeted approach to medical treatment. In the case of gastrointestinal stromal tumors, precision medicine involves molecular profiling to identify specific mutations, guiding therapies such as imatinib. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research approved 37 new molecular entities, with 34% classified as personalized medicines. This rise in precision medicine adoption contributes to the growth of the gastrointestinal stromal tumor market.

The limitation of health awareness and literacy is anticipated to hinder the growth of the gastrointestinal stromal tumors (GIST) market. Limited awareness of safety regulations and guidelines can lead to accidents and injuries when handling drums, similar to the constraints faced in gastrointestinal stromal tumor management due to a lack of awareness about chronic disease treatment. Enhancing awareness within healthcare and research communities and among the general public is crucial to addressing cancer as a significant health issue. Therefore, the lack of health awareness and literacy significantly constrains the growth potential of the gastrointestinal stromal tumors market, hindering improvements in patient outcomes.

Major companies in the gastrointestinal stromal tumor market are introducing innovative drugs such as QINLOCK (Ripretinib) to cater to larger customer bases, boost sales, and increase revenue. QINLOCK (Ripretinib) is a prescription medicine approved for the treatment of advanced gastrointestinal stromal tumor (GIST). For instance, Zai Lab Ltd, a China-based biotechnology company, announced the approval of QINLOCK (Ripretinib) by the National Medical Products Administration (NMPA) of China in March 2021. This drug is prescribed for the treatment of advanced GIST in adult patients who have previously undergone treatment with three or more kinase inhibitors, including imatinib.

In June 2022, Immatics N.V., a Germany-based biotechnology company, formed a partnership with Bristol Myers Squibb to develop gamma delta allogeneic cell therapy programs. This collaboration aims to create advanced cancer immunotherapies with the potential to enhance the treatment of various cancers, including gastrointestinal stromal tumors (GISTs). Bristol Myers Squibb, a US-based pharmaceutical company, is actively involved in developing treatments related to GISTs.

Major companies operating in the gastrointestinal stromal tumor market report are Pfizer Inc., F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Merck & Co. Inc., GlaxoSmithKline plc, Bristol-Myers Squibb Company, Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Jiangsu Hengrui Medicine Co. Ltd., Exelixis Inc., NATCO Pharma Ltd., Blueprint Medicines Corporation, Array BioPharma Inc., Deciphera Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Boston Biomedical Inc., DNAtrix Inc., Advenchen Laboratories LLC, Arog Pharmaceuticals Inc., AB Sciences S.A.

North America was the largest region in the gastrointestinal stromal tumor market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal stromal tumor market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the gastrointestinal stromal tumor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The gastrointestinal stromal tumor market includes revenues earned by entities by providing services such as diagnostic services, pathology services, pathology services, and pathology services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastrointestinal stromal tumor market also includes sales of targeted therapy, chemotherapy, radiation therapy. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastrointestinal Stromal Tumor Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastrointestinal stromal tumor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastrointestinal stromal tumor? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastrointestinal stromal tumor market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Treatment Type: Chemotherapy; Targeted Therapy; Other Treatment Types
2) By Indication: Stomach; Small Intestine; Others Indications
3) By End-User: Hospitals; Clinics; Specialized Cancer Treatment Centers; Other End-Users
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Bayer AG; Novartis AG; Merck & Co. Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r13461

1. Executive Summary

2. Gastrointestinal Stromal Tumor Market Characteristics

3. Gastrointestinal Stromal Tumor Market Trends And Strategies

4. Gastrointestinal Stromal Tumor Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Gastrointestinal Stromal Tumor Market Size and Growth

5.1. Global Gastrointestinal Stromal Tumor Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Gastrointestinal Stromal Tumor Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Gastrointestinal Stromal Tumor Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Gastrointestinal Stromal Tumor Market Segmentation

6.1. Global Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Chemotherapy
Targeted Therapy
Other Treatment Types
6.2. Global Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Stomach
Small Intestine
Others Indications
6.3. Global Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Clinics
Specialized Cancer Treatment Centers
Other End-Users

7. Gastrointestinal Stromal Tumor Market Regional And Country Analysis

7.1. Global Gastrointestinal Stromal Tumor Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Gastrointestinal Stromal Tumor Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Gastrointestinal Stromal Tumor Market

8.1. Asia-Pacific Gastrointestinal Stromal Tumor Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Gastrointestinal Stromal Tumor Market

9.1. China Gastrointestinal Stromal Tumor Market Overview
9.2. China Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Gastrointestinal Stromal Tumor Market

10.1. India Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Gastrointestinal Stromal Tumor Market

11.1. Japan Gastrointestinal Stromal Tumor Market Overview
11.2. Japan Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Gastrointestinal Stromal Tumor Market

12.1. Australia Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Gastrointestinal Stromal Tumor Market

13.1. Indonesia Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Gastrointestinal Stromal Tumor Market

14.1. South Korea Gastrointestinal Stromal Tumor Market Overview
14.2. South Korea Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Gastrointestinal Stromal Tumor Market

15.1. Western Europe Gastrointestinal Stromal Tumor Market Overview
15.2. Western Europe Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Gastrointestinal Stromal Tumor Market

16.1. UK Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Gastrointestinal Stromal Tumor Market

17.1. Germany Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Gastrointestinal Stromal Tumor Market

18.5. France Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Gastrointestinal Stromal Tumor Market

19.9. Italy Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Gastrointestinal Stromal Tumor Market

20.13. Spain Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Gastrointestinal Stromal Tumor Market

21.1. Eastern Europe Gastrointestinal Stromal Tumor Market Overview
21.2. Eastern Europe Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Gastrointestinal Stromal Tumor Market

22.1. Russia Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Gastrointestinal Stromal Tumor Market

23.1. North America Gastrointestinal Stromal Tumor Market Overview
23.2. North America Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Gastrointestinal Stromal Tumor Market

24.1. USA Gastrointestinal Stromal Tumor Market Overview
24.2. USA Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Gastrointestinal Stromal Tumor Market

25.1. Canada Gastrointestinal Stromal Tumor Market Overview
25.2. Canada Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Gastrointestinal Stromal Tumor Market

26.1. South America Gastrointestinal Stromal Tumor Market Overview
26.2. South America Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Gastrointestinal Stromal Tumor Market

27.1. Brazil Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Gastrointestinal Stromal Tumor Market

28.1. Middle East Gastrointestinal Stromal Tumor Market Overview
28.2. Middle East Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Gastrointestinal Stromal Tumor Market

29.1. Africa Gastrointestinal Stromal Tumor Market Overview
29.2. Africa Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Gastrointestinal Stromal Tumor Market Competitive Landscape And Company Profiles

30.1. Gastrointestinal Stromal Tumor Market Competitive Landscape
30.2. Gastrointestinal Stromal Tumor Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. F. Hoffmann-La Roche AG
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Bayer AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Novartis AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Merck & Co. Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Gastrointestinal Stromal Tumor Market Other Major And Innovative Companies

31.1. GlaxoSmithKline plc
31.2. Bristol-Myers Squibb Company
31.3. Sanofi S.A.
31.4. AstraZeneca plc
31.5. Eli Lilly and Company
31.6. Daiichi Sankyo Co. Ltd.
31.7. Eisai Co. Ltd.
31.8. Sun Pharmaceutical Industries Limited
31.9. Jiangsu Hengrui Medicine Co. Ltd.
31.10. Exelixis Inc.
31.11. NATCO Pharma Ltd.
31.12. Blueprint Medicines Corporation
31.13. Array BioPharma Inc.
31.14. Deciphera Pharmaceuticals Inc.
31.15. Ono Pharmaceutical Co. Ltd.

32. Global Gastrointestinal Stromal Tumor Market Competitive Benchmarking

33. Global Gastrointestinal Stromal Tumor Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Gastrointestinal Stromal Tumor Market

35. Gastrointestinal Stromal Tumor Market Future Outlook and Potential Analysis

35.1 Gastrointestinal Stromal Tumor Market In 2028 - Countries Offering Most New Opportunities
35.2 Gastrointestinal Stromal Tumor Market In 2028 - Segments Offering Most New Opportunities
35.3 Gastrointestinal Stromal Tumor Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer